Regional Health Properties, Inc. (RHEP)
OTCMKTS · Delayed Price · Currency is USD
1.350
0.00 (0.00%)
Jan 16, 2026, 4:00 PM EST
RHEP Market Cap
RHEP has a market cap or net worth of $5.06 million as of January 20, 2026. Its market cap has increased by 84.50% in one year.
Market Cap
5.06M
Enterprise Value
76.11M
Revenue
37.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.35
Market Cap Chart
Since October 2, 2017, RHEP's market cap has decreased from 233.80M to 5.06M, a decrease of -97.83%. That is a compound annual growth rate of -37.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 5.06M | 5.47% |
| Dec 31, 2025 | 4.80M | 63.33% |
| Dec 31, 2024 | 2.94M | -17.65% |
| Dec 29, 2023 | 3.57M | -38.01% |
| Dec 30, 2022 | 5.76M | -24.72% |
| Dec 31, 2021 | 7.65M | 27.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 723.02M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |